Outset Medical OM Cash Flow Statement (2019-2026)

NASDAQ OM
$3.23 -0.08 (-2.42%)
As of: Sep 10, 2026 · 2:56 PM EDT
Reported Financials

Outset Medical Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Outset Medical reported cash from operations of -$9.63M and free cash flow of -$9.75M for the quarter ended Jun 2026, down 99.8% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-30.47M-41.23M-36.89M-43.84M-40.78M-41.44M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.64M-25.78M-18.54M-17.84M-1.78M-18.98M-17.98M
Share-based CompensationStock Comp.
2.86M4.79M5.01M7.41M7.43M7.35M8.54M10.11M10.89M9.10M8.20M9.82M6.39M4.95M2.98M3.50M5.08M4.06M3.45M2.70M
Gains from Investment SecuritiesGains Investment
4.37M
Asset Writedowns and ImpairmentWritedown
Cash from OperationsCash from Ops.
-28.13M-32.68M-38.34M-38.58M-34.31M-34.51M-44.76M-28.18M-34.00M-24.44M-45.91M-33.34M-20.57M-16.49M-25.66M-4.82M-6.32M-9.52M-12.84M-9.63M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-0.74M-0.80M-0.67M-0.37M-0.05M0.63M1.55M1.80M1.75M1.27M1.58M1.35M0.96M0.83M0.40M0.63M0.69M0.54M0.41M0.39M
Depreciation & Amortization (CF)Dep. & Amort.
1.31M1.30M1.26M1.32M1.31M1.27M1.38M1.51M1.47M1.45M1.46M1.47M1.39M1.41M1.29M1.16M1.01M0.88M0.80M0.63M
Change in Working Capital
Change in ReceivablesChange Receivables
2.89M6.30M1.30M-2.26M-2.12M5.58M6.22M2.69M-1.35M-2.47M3.50M-0.54M0.14M1.92M1.47M-0.57M-2.90M-1.77M-3.41M5.04M
Change in InventoryChange Inventory
5.81M4.12M4.18M11.13M2.38M-2.96M-2.87M-3.24M3.51M0.96M6.98M6.23M-0.23M-2.13M-3.69M-3.61M-3.00M-1.49M2.24M-2.34M
Change in Account PayablesChange Payables
0.36M-0.92M3.28M-2.59M-1.26M-0.71M1.48M0.21M0.57M3.06M0.94M-1.49M-0.96M-0.44M-2.77M0.27M0.34M-1.13M0.86M2.97M
Change in Accured ExpensesChange Accured Exp.
5.03M4.61M-11.47M2.32M3.48M2.25M-7.10M3.04M-0.05M1.49M-4.46M-2.82M0.95M1.16M-8.58M1.55M1.07M-0.12M2.17M1.32M
Investing Activities
Capital ExpendituresCapex
0.49M0.85M1.48M2.00M2.74M2.11M0.81M0.80M0.78M1.05M0.35M0.12M0.40M0.04M0.12M0.29M0.16M0.22M0.07M0.11M
Change in Acquisitions & DivestmentsChange Acquisitions
4.40M14.73M32.80M68.98M58.50M42.90M71.60M57.65M54.00M75.50M39.98M68.85M38.29M114.31M18.38M26.45M43.22M37.03M30.86M32.92M
Cash from Investing ActivitiesCash from Investing
-21.82M-16.42M-33.39M-1.32M20.16M-51.75M2.64M27.15M29.80M23.43M-59.03M38.94M15.88M108.15M-78.08M-31.16M2.97M8.59M7.90M14.17M
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
6.19M0.93M3.72M1.04M2.53M65.60M5.28M1.04M4.10M33.23M68.61M0.08M0.12M-0.94M55.66M-0.38M0.23M0.50M-0.09M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.63M142.0082.000.48M0.01M
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Change in Cash
-43.77M-48.16M-68.00M-38.85M-11.62M-20.66M-36.84M0.02M-0.09M32.21M-36.33M5.68M-4.57M90.73M-48.09M-36.37M-3.12M-0.93M-4.44M4.44M
Free Cash FlowFCF
-28.62M-33.53M-39.81M-40.57M-37.05M-36.62M-45.57M-28.97M-34.78M-25.50M-46.27M-33.45M-20.96M-16.53M-25.79M-5.12M-6.48M-9.74M-12.91M-9.75M
Net Cash FlowNCF
-43.77M-48.16M-68.00M-38.85M-11.62M-20.66M-36.84M0.02M-0.09M32.21M-36.33M5.68M-4.57M90.73M-48.09M-36.37M-3.12M-0.93M-4.44M4.44M